The University of Chicago Header Logo

Connection

Stephen Hanauer to Patient Selection

This is a "connection" page, showing publications Stephen Hanauer has written about Patient Selection.
Connection Strength

0.724
  1. Subgroups. Nat Clin Pract Gastroenterol Hepatol. 2008 Jan; 5(1):1.
    View in: PubMed
    Score: 0.229
  2. Novel potential perils of volunteering for clinical trials. Nat Clin Pract Gastroenterol Hepatol. 2005 Aug; 2(8):337.
    View in: PubMed
    Score: 0.193
  3. Shared experiences and best practices in the management of rheumatoid arthritis and Crohn's disease. Am J Med. 2011 Apr; 124(4 Suppl):e1-18.
    View in: PubMed
    Score: 0.072
  4. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response? Am J Gastroenterol. 2011 Feb; 106(2):199-212; quiz 213.
    View in: PubMed
    Score: 0.070
  5. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology. 2006 Feb; 130(2):323-33; quiz 591.
    View in: PubMed
    Score: 0.050
  6. Top-down versus step-up approaches to chronic inflammatory bowel disease: presumed innocent or presumed guilty. Nat Clin Pract Gastroenterol Hepatol. 2005 Nov; 2(11):493.
    View in: PubMed
    Score: 0.049
  7. Treatment of Crohn's disease: the "long" of it. Gastroenterology. 2005 Jun; 128(7):2164-6.
    View in: PubMed
    Score: 0.048
  8. Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial. Gastroenterology. 2008 Mar; 134(3):688-95.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.